EUVIMEDEUVIMED entdecken
Open Access

Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells

Abdulaziz Ahmed A Saad, Lichen Ge, Haoran Wang, Yan Xia, Jianing Li, Shiyao Qiao, Cheng Yi, Xiansong Wang, Zhaotong Wang, Dan Zhou, Hongsheng Wang

International Journal of Biological Sciences · 27.10.2025 · 21 (15) · 7063-7085

DOI: 10.7150/ijbs.117999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 27.10.2025. Verfasst von Abdulaziz Ahmed A Saad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, The State Key Laboratory of Anti-Infective Drug Discovery and Development,…. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Agammaglobulinaemia Tyrosine Kinase, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alpha-Ketoglutarate-Dependent Dioxygenase FTOAgammaglobulinaemia Tyrosine KinaseBreast NeoplasmsHumansCell Line, TumorHeterograftsNeoplasm TransplantationAdeninePiperidinesDrug SynergismDisease Models, Animal

Stichwörter der Autor:innen

Breast cancerE2F1FTO inhibitor FB23Ibrutinibc-Myc

Substanzen

FTO protein, humanAlpha-Ketoglutarate-Dependent Dioxygenase FTOBTK protein, humanAgammaglobulinaemia Tyrosine KinaseibrutinibAdeninePiperidines

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, The State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou…
  • Department of Laboratory Medicine, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
  • Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
  • Department of Breast Surgery, Southern University of Science and Technology Affiliated Foshan Hospital (The First People's Hospital of Foshan), Foshan 528000, Guangdong Province, China.

Zitieren

APA

Saad, A. A. A., Ge, L., Wang, H., Xia, Y., Li, J., Qiao, S., Yi, C., Wang, X., Wang, Z., Zhou, D., & Wang, H. (2025). Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells. International Journal of Biological Sciences, 21(15), 7063-7085. https://doi.org/10.7150/ijbs.117999

Vancouver

Saad AAA, Ge L, Wang H, Xia Y, Li J, Qiao S, et al. Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells. International Journal of Biological Sciences. 2025;21(15):7063-7085. doi:10.7150/ijbs.117999

BibTeX
@article{Saad2025,
  author = {Saad, Abdulaziz Ahmed A and Ge, Lichen and Wang, Haoran and Xia, Yan and Li, Jianing and Qiao, Shiyao and Yi, Cheng and Wang, Xiansong and Wang, Zhaotong and Zhou, Dan and Wang, Hongsheng},
  title = {Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {15},
  pages = {7063--7085},
  doi = {10.7150/ijbs.117999}
}
Kostenlos starten →